Susi Roger E. 4
4 · IRADIMED CORP · Filed Mar 25, 2026
Research Summary
AI-generated summary of this filing
IRADIMED (IRMD) 10% Owner Roger E. Susi Sells Shares
What Happened
Roger E. Susi, a reported 10% owner of IRADIMED Corp (IRMD), sold a total of 7,500 shares in open-market transactions on March 23–24, 2026, generating approximately $752,610 in proceeds. The sales break down as: 2,950 shares at a weighted average $99.58 ($293,761), 750 shares at $100.70 ($75,525), 1,300 shares at $102.02 ($132,626), 1,585 shares at $100.03 ($158,548), and 915 shares at $100.71 ($92,150). All transactions are reported as sales (S), so this is a disposition, not a purchase.
Key Details
- Transaction dates: March 23–24, 2026; Form 4 filed March 25, 2026 (timely filing).
- Total shares sold: 7,500; total proceeds: ~$752,610.
- Individual trades (weighted avg prices / proceeds):
- 3/23: 2,950 @ $99.58 = $293,761 (prices ranged $99.02–$100.00)
- 3/23: 750 @ $100.70 = $75,525 (prices ranged $100.05–$100.97)
- 3/23: 1,300 @ $102.02 = $132,626 (prices ranged $102.00–$102.08)
- 3/24: 1,585 @ $100.03 = $158,548 (prices ranged $99.49–$100.40)
- 3/24: 915 @ $100.71 = $92,150 (prices ranged $100.53–$100.97)
- Footnotes: Sales were effected under a Rule 10b5-1 trading plan adopted Nov 5, 2025 (F1). Multiple trades produced the reported weighted-average prices; the filer will provide trade-level details on request (F2–F6). The filer disclaims beneficial ownership except to the extent of pecuniary interest (F7).
- Filing timeliness: Transactions occurred 3/23–3/24 and the Form 4 was filed 3/25 — no late-filing indication.
Context: Susi is a 10% owner (large shareholder) rather than an executive; sales under an established 10b5-1 plan are typically pre-planned dispositions and do not necessarily signal a change in view about the company. This report documents dispositions only — no purchases, exercises, or awards were reported.
Insider Transaction Report
Form 4
IRADIMED CORPIRMD
Susi Roger E.
DirectorCEO, President, Chairman10% Owner
Transactions
- Sale
Common Stock
[F1][F2]2026-03-23$99.58/sh−2,950$293,761→ 2,237,050 total(indirect: By Trust) - Sale
Common Stock
[F1][F3]2026-03-23$100.70/sh−750$75,525→ 2,236,300 total(indirect: By Trust) - Sale
Common Stock
[F1][F4]2026-03-23$102.02/sh−1,300$132,626→ 2,235,000 total(indirect: By Trust) - Sale
Common Stock
[F1][F5]2026-03-24$100.03/sh−1,585$158,548→ 2,233,415 total(indirect: By Trust) - Sale
Common Stock
[F1][F6]2026-03-24$100.71/sh−915$92,150→ 2,232,500 total(indirect: By Trust)
Holdings
- 162,950(indirect: By Trust)
Common Stock
- 2,062,500(indirect: By Trust)
Common Stock
[F7]
Footnotes (7)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $99.02 to $100.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $100.05 to $100.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $102.00 to $102.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $99.49 to $100.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $100.53 to $100.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F7]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.
Signature
/s/ Roger E. Susi|2026-03-25